Marco Donato
Messina, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Feasibility and safety of recombinant zoster vaccination in patients undergoing active cancer treatments: A real-world single-center experience.
Journal: Human vaccines & immunotherapeutics
Published: July 30, 2026
Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 14, 2026
Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 23, 2025
Long-Term Complete Radiological Response in a Patient with Brain Metastases from HER2-Positive Breast Cancer Treated with Trastuzumab Deruxtecan: A Case Report and Literature Review.
Journal: Case reports in oncology
Published: December 17, 2025
ABCB1 Polymorphisms Influence on Temozolomide Resistance and Overall Survival in Glioblastoma Patients: A Systematic Review of Clinical Evidence.
Journal: Journal of cellular and molecular medicine
Published: December 12, 2025
Prognostic significance of circulating tumor DNA in early breast cancer: a systematic review and meta-analysis.
Journal: Breast cancer research and treatment
Published: November 07, 2025
Immunotherapy in rare histologies of breast cancer: challenges, opportunities, and future perspectives.
Journal: Current opinion in oncology
Published: August 21, 2025
Comparative real-world progression free survival of CDK4/6 inhibitors in HR+/HER2- breast cancer patients with bone metastases.
Journal: The oncologist
Published: June 13, 2025
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors.
Journal: Breast (Edinburgh, Scotland)
Published: October 22, 2024
New steps on an old path: Novel estrogen receptor inhibitors in breast cancer.
Journal: Critical reviews in oncology/hematology
Published: October 13, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026